Journal of Cancer Research and Clinical Oncology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.3 | Q2 | 52.9% | 0.954 | Q1 | 82.7% |
| 2024 | 2.8 | Q2 | 51.2% | 0.910 | Q1 | 81.7% |
| 2023 | 2.7 | Q3 | 46.0% | 1.023 | Q1 | 86.0% |
| 2022 | 3.6 | Q2 | 54.5% | 1.017 | Q1 | 86.6% |
| 2021 | 4.3 | Q3 | 58.8% | 1.058 | Q1 | 87.7% |
| 2020 | — | — | 1.338 | Q1 | 90.8% | |
| 2019 | — | — | 1.111 | Q1 | 87.8% | |
| 2018 | — | — | 1.103 | Q1 | 86.3% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1432-1335
ISSN
0171-5216
region
Western Europe
coverage
1979-2026
